-
SAR131675: Precision VEGFR-3 Inhibitor for Fibrosis & Tumor
2026-05-31
SAR131675, a selective ATP-competitive VEGFR-3 inhibitor from APExBIO, delivers nanomolar pathway specificity for dissecting lymphangiogenesis in fibrosis and oncology models. Its robust in vivo and in vitro performance empowers researchers to unravel VEGFC-VEGFR-3 signaling with exceptional reproducibility and translational relevance.
-
Surrogate Blood-Brain Barrier Model: High-Throughput Permeab
2026-05-30
This study introduces a robust in vitro blood-brain barrier (BBB) model combining LLC-PK1-MOCK/MDR1 cells and a lysosomal trapping correction to predict CNS drug permeability. The model demonstrates strong predictive accuracy, enhancing early-stage screening and prioritization of brain-penetrant compounds.
-
ABCC10 Drives cGAMP Efflux and Radiotherapy Resistance in Ca
2026-05-29
This study uncovers ABCC10 as a crucial efflux transporter of 2'3'-cGAMP, demonstrating its role in dampening STING-mediated immune responses and promoting radiotherapy resistance in cancer cells. These findings provide a mechanistic basis for targeting ABCC10 to enhance radiosensitivity and inform future strategies for overcoming tumor immune evasion.
-
Leptin (116-130), amide, mouse: Applied Workflows & Troubles
2026-05-29
Leptin (116-130), amide, mouse empowers obesity and diabetes research with targeted, reproducible modeling of leptin signaling. This guide delivers actionable protocols, advanced use-cases, and troubleshooting insights, ensuring robust results for energy homeostasis and immunometabolic studies.
-
Targeted mRNA Nanoparticles Restore BBB After Ischemic Strok
2026-05-28
This study demonstrates a lipid nanoparticle platform that delivers IL-10 mRNA to ischemic brain regions, promoting microglial polarization toward a protective phenotype and restoring blood-brain barrier integrity after stroke. The findings highlight a positive feedback loop enhancing therapeutic mRNA targeting, with implications for extending the stroke intervention window.
-
CCR7–Notch1 Crosstalk Drives Stemness in MMTV-PyMT Breast Ca
2026-05-28
Boyle et al. (2017) demonstrate that CCR7 and Notch1 signaling converge to promote stem-like properties in mammary tumor cells, advancing understanding of breast cancer recurrence. This mechanistic insight suggests that dual targeting of CCR7 and Notch1 may be a promising therapeutic strategy to combat cancer stem cell-driven resistance.
-
PDHA1 Succinylation Drives Immune Evasion in Cholangiocarcin
2026-05-27
This study uncovers how succinylation at lysine 83 of PDHA1 reprograms metabolism in cholangiocarcinoma, leading to immune evasion via α-ketoglutaric acid accumulation and impaired macrophage antigen presentation. Inhibiting PDHA1 succinylation with CPI-613 sensitizes tumors to gemcitabine–cisplatin, highlighting a promising avenue for overcoming chemoresistance.
-
ECL Chemiluminescent Substrate Detection Kit: Precision in L
2026-05-27
Explore how the ECL Chemiluminescent Substrate Detection Kit enables reliable immunoblotting detection of low-abundance proteins with exceptional sensitivity. This article uniquely links scientific insights on oxidative stress biomarkers to advanced Western blot strategies, optimizing research outcomes.
-
PNU 74654: Precision Wnt Pathway Inhibition for Cell Fate Re
2026-05-26
Explore how PNU 74654, a selective Wnt signaling pathway inhibitor, enables advanced mechanistic studies in cell proliferation and differentiation. This article delves into new insights on Wnt/β-catenin modulation, bridging molecular detail with practical assay design.
-
CAPE Inhibits C. difficile Toxins and Modulates Gut Microbio
2026-05-26
Guo et al. demonstrate that caffeic acid phenethyl ester (CAPE) directly inhibits TcdB toxin activity and beneficially alters gut microbiota in Clostridioides difficile infection models. This study introduces CAPE as a mechanistically distinct antivirulence strategy, with implications for antibiotic resistance research and microbiome-focused therapies.
-
Lypressin Acetate: Precision Peptide for Vasopressin and Ant
2026-05-25
Explore the scientific foundations and emerging applications of Lypressin acetate, a lysine vasopressin analog, with a focus on mechanistic insight and cross-domain utility. This article offers advanced protocol guidance and critical analysis for researchers seeking robust, translational outcomes.
-
Norovirus Exploits NINJ1 for Selective Viral Protein Secreti
2026-05-25
Song et al. uncover how murine norovirus commandeers the host protein NINJ1 to enable selective secretion of the viral NS1 protein, revealing new mechanistic links between viral infection, apoptosis, and unconventional protein trafficking. These findings have broad implications for understanding regulated cell death and immune evasion strategies in viral pathogenesis.
-
S Tag Peptide: Technical Guide for Fusion Tag Applications
2026-05-24
S Tag Peptide enables efficient recombinant protein detection and purification workflows by improving solubility and allowing anti-S-Tag antibody-based assays. It is best applied as a genetic fusion tag for proteins expressed in systems where ethanol solubility is not required. It should not be used for standalone enzymatic activity or in protocols demanding non-aqueous solubility.
-
Angiotensin I in Renin-Angiotensin System Research Workflows
2026-05-23
Angiotensin I (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu) is a cornerstone tool for dissecting renin-angiotensin system mechanisms and modeling cardiovascular disease. This article translates recent findings into actionable protocols, advanced applications, and troubleshooting strategies for labs seeking reproducible results.
-
Wortmannin and the PI3K Pathway: Unraveling Ferroptosis Resi
2026-05-22
Explore how Wortmannin, a potent PI3K inhibitor, enables advanced cancer research through its impact on ferroptosis and signaling pathways. This article uniquely bridges mechanistic insight with practical assay design using the latest findings in hepatocellular carcinoma.